Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study59

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study45

Views

Views
January 20251
February 20250
March 202516
April 20252
May 20253
June 202514
July 20259
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Hong Kong11
United States6
Brazil5
United Kingdom3
South Africa2
Argentina1
Spain1
 

Top cities views

Views
Hong Kong11
Belo Horizonte1
Brasília1
Cape Town1
Chicago1
Cotia1
Council Bluffs1
Forquilhinha1
Johannesburg1
Memphis1